This collaboration will combine Aqua Membranes' innovative 3D printed spacer technology for reverse osmosis (RO) membranes with Osmoflo’s integration and operational expertise in delivering innovative water and wastewater treatment solutions.
With the support of its Japanese shareholder Kanadevia Corporation, Osmoflo has also taken an investment position, as part of Aqua Membranes Series B fund raising activities, to enable further expansion of its US manufacturing capacity and global supply capabilities.
Under this exclusive agreement, Osmoflo will distribute Aqua Membranes’ groundbreaking RO membrane incorporating its patented 3D-printed spacer technology to clients, asset owners and OEMs across Australia, New Zealand and the Pacific, as well as utilising these membranes within its own integrated water treatment systems and processes. The partnership will focus on delivering next-generation and optimized desalination solutions across both the industrial and municipal sectors.
Neil Palmer, Osmoflo’s chief technology officer (CTO), said: “Aqua Membranes’ new approach to feed spacer technology is one of the most significant advances of RO technology since the development of thin film composite some 50 years ago. We have tested the new membranes over a long period on challenging industrial water and the results have exceeded our expectations”.
Craig Beckman, CEO of Aqua Membranes, added: "We are thrilled to announce this investment and distribution agreement between Osmoflo and Aqua Membranes. Osmoflo is an exceptional company that shares our commitment to developing innovative solutions to address the ever-evolving water crisis. We look forward to collaborating with them to demonstrate the effectiveness of our Printed Spacer Technology."
Carmine Ciccocioppo, CEO of Osmoflo, said: “We are excited by the opportunities that this exclusive partnership with Aqua Membranes and the use of their groundbreaking membrane product present for Osmoflo – indeed, we have already observed its impressive performance compared to conventional spiral wound membranes in several of our plants over the last 12–18 months. This partnership further enables us to deliver on our core mission of providing innovative, sustainable and value-based water solutions that contribute to a circular economy.”
